X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3521) 3521
Publication (165) 165
Newsletter (90) 90
Magazine Article (18) 18
Newspaper Article (16) 16
Dissertation (10) 10
Book Review (8) 8
Web Resource (5) 5
Paper (4) 4
Book Chapter (2) 2
Trade Publication Article (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ramipril (2196) 2196
humans (1885) 1885
male (1540) 1540
female (1068) 1068
angiotensin-converting enzyme inhibitors - therapeutic use (1050) 1050
ramipril - therapeutic use (1037) 1037
middle aged (853) 853
index medicus (763) 763
animals (756) 756
hypertension (694) 694
hypertension - drug therapy (676) 676
aged (656) 656
angiotensin-converting enzyme inhibitors - pharmacology (614) 614
ramipril - pharmacology (595) 595
blood pressure - drug effects (592) 592
cardiac & cardiovascular systems (556) 556
rats (553) 553
adult (508) 508
pharmacology & pharmacy (491) 491
antihypertensive agents - therapeutic use (480) 480
peripheral vascular disease (463) 463
treatment outcome (425) 425
ramipril - administration & dosage (357) 357
risk factors (351) 351
drug therapy, combination (345) 345
medicine, general & internal (304) 304
ace inhibitors (295) 295
double-blind method (287) 287
hypertension - physiopathology (279) 279
mortality (273) 273
angiotensin-converting enzyme inhibitors - administration & dosage (269) 269
blood-pressure (256) 256
blood pressure (243) 243
captopril (241) 241
telmisartan (235) 235
time factors (229) 229
angiotensin (228) 228
angiotensin-converting enzyme inhibitors (228) 228
prevention (227) 227
angiotensin-converting enzyme inhibitors - adverse effects (223) 223
urology & nephrology (222) 222
ramipril - adverse effects (218) 218
drug therapy (216) 216
risk (205) 205
research (196) 196
cardiovascular diseases - prevention & control (195) 195
heart-failure (194) 194
diabetes (186) 186
randomized controlled trials as topic (186) 186
prospective studies (183) 183
renin-angiotensin system - drug effects (183) 183
cardiovascular events (180) 180
enalapril (180) 180
disease (178) 178
follow-up studies (177) 177
dose-response relationship, drug (176) 176
ramipril - analogs & derivatives (175) 175
trial (174) 174
antihypertensive agents - pharmacology (172) 172
benzimidazoles - therapeutic use (170) 170
bradykinin (170) 170
hypertension - complications (169) 169
antihypertensive agents - administration & dosage (165) 165
angiotensin ii type 1 receptor blockers - therapeutic use (162) 162
renin-angiotensin system (155) 155
losartan (154) 154
myocardial-infarction (153) 153
heart failure (147) 147
benzoates - therapeutic use (146) 146
rats, sprague-dawley (143) 143
enzymes (135) 135
angiotensin-converting enzyme (134) 134
analysis (131) 131
care and treatment (130) 130
bradykinin - pharmacology (128) 128
proteinuria (126) 126
dosage and administration (125) 125
heart failure - drug therapy (125) 125
cardiovascular diseases (124) 124
nephropathy (122) 122
clinical trials as topic (119) 119
health aspects (119) 119
rats, inbred shr (118) 118
antihypertensive agents - adverse effects (117) 117
bridged bicyclo compounds - pharmacology (117) 117
cardiovascular disease (117) 117
cardiovascular diseases - drug therapy (116) 116
progression (116) 116
aged, 80 and over (112) 112
rats, wistar (112) 112
therapy (112) 112
medicine & public health (109) 109
valsartan (109) 109
myocardial infarction - drug therapy (108) 108
atherosclerosis (107) 107
hemodynamics - drug effects (106) 106
stroke (106) 106
disease progression (105) 105
myocardial infarction (104) 104
outcomes (101) 101
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3239) 3239
German (167) 167
Russian (77) 77
French (56) 56
Spanish (27) 27
Chinese (18) 18
Hungarian (16) 16
Italian (14) 14
Polish (11) 11
Croatian (9) 9
Japanese (7) 7
Portuguese (7) 7
Czech (5) 5
Turkish (3) 3
Ukrainian (3) 3
Korean (2) 2
Lithuanian (2) 2
Swedish (2) 2
Danish (1) 1
Dutch (1) 1
Finnish (1) 1
Hebrew (1) 1
Norwegian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Acta Ophthalmologica, ISSN 1755-375X, 09/2012, Volume 90
Purpose to assess the effect of Ramipril 2% eyedrops on visual function in patients with Stargardt’s disease. Methods We conducted a prospective,... 
Ramipril
Journal Article
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 2007, Volume 66, Issue 2, pp. 227 - 243
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 06/2019, Volume 40, p. A148
Le syndrome des antisynthetases est une connectivite rare caracterisee par l'association d'atteintes cutanees, musculaires, pulmonaires interstitielles,... 
RNA | Ramipril
Journal Article
Medizinische Klinik, ISSN 0723-5003, 01/2010, Volume 105, Issue 1, p. 26
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 10/2015, Volume 765, pp. 307 - 315
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9638, pp. 547 - 553
Summary Background Angiotensin receptor blockers (ARB) and angiotensin converting enzyme (ACE) inhibitors are known to reduce proteinuria. Their combination... 
Internal Medicine | COOPERATE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | RENIN-ANGIOTENSIN SYSTEM | DISEASE | PROTEINURIA | CONVERTING ENZYME-INHIBITORS | COMBINATION | NEPHROPATHY | II RECEPTOR BLOCKERS | PROGRESSION | Benzoates - adverse effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Benzoates - therapeutic use | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Ramipril - administration & dosage | Proteinuria - chemically induced | Cardiovascular Diseases - complications | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Benzimidazoles - administration & dosage | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Ramipril - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | Ramipril - adverse effects | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Benzimidazoles - therapeutic use | Kidney - drug effects | Double-Blind Method | Diabetes Mellitus - drug therapy | Proteinuria - metabolism | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Creatinine - urine | Benzoates - administration & dosage | Creatinine - blood | Aged | Urine | Drugs | Studies | Kidneys | Disease | Clinical trials | Risk | ACE inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2009, Volume 361, Issue 17, pp. 1639 - 1650
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2008, Volume 358, Issue 15, pp. 1547 - 1559
This large trial compared the angiotensin-receptor blocker telmisartan, the angiotensin-converting–enzyme inhibitor ramipril, and combination therapy with both... 
MEDICINE, GENERAL & INTERNAL | DESIGN | LEFT-VENTRICULAR DYSFUNCTION | MYOCARDIAL-INFARCTION | CARDIOVASCULAR EVENTS | DOUBLE-BLIND | SYSTOLIC DYSFUNCTION | RANDOMIZED CLINICAL-TRIALS | CONGESTIVE-HEART-FAILURE | COMBINATION | CONVERTING-ENZYME-INHIBITORS | Benzoates - adverse effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Benzoates - therapeutic use | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Male | Risk | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Ramipril - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | Ramipril - adverse effects | Benzimidazoles - therapeutic use | Double-Blind Method | Diabetes Mellitus - drug therapy | Kaplan-Meier Estimate | Hospitalization | Creatinine - blood | Angioedema - chemically induced | Aged | Complications and side effects | Ramipril | Drug therapy, Combination | Diabetes | Cardiovascular diseases | Drug therapy | Comparative analysis | Risk factors | Telmisartan | Clinical trials | Vein & artery diseases | Cardiovascular disease | Pharmacology | Clinical outcomes | Index Medicus | Abridged Index Medicus | Blood Pressure | Benzimidazoles | Cardiovascular Diseases | MEDICIN OCH HÄLSOVETENSKAP | Angiotensin II Type 1 Receptor Blockers | epidemiology | Angiotensin-Converting Enzyme Inhibitors | Combination | MEDICAL AND HEALTH SCIENCES | Creatinine | chemically induced | Benzoates | drug therapy | Angioedema | drug effects | Diabetes Mellitus | blood | adverse effects | mortality | therapeutic use | Kaplan-Meiers Estimate
Journal Article
by Bosch, Jackie and Yusuf, Salim and Gerstein, Hertzel C and Pogue, Janice and Sheridan, Patrick and Dagenais, Gilles and Chiasson, Jean Louis and Diaz, Rafael and Avezum, Alvaro and Lanas, Fernando and Probstfield, Jeffrey and Fodor, George and Holman, Rury R and Anand, S and Budaj, A and Conget, I and Davis, M and Dinccag, N and Enjalbert, M and Escalante, A and Hanefeld, M and Hedner, T and Jolly, K and Keltai, M and Laakso, M and Lonn, E and McQueen, M and Mohan, V and Phillips, A and Piegas, L and Pirags, V and Schmid, I and Shaw, J and Teo, K and Zimmet, P and Zinman, B and Ahuad Guerrero, R and Albisu, J and Alvarez, M.S and Arregui, V and Avaca, H and Baglivo, H and Balbuena, M and Bello, F and Bono, J and Botto, M and Brandani, L and Brandes, M and Bruera, D and Cabral Venere, R and Caccavo, A and Cacurri, A and Caime, G and Capozzi, M and Carrique, A and Carrique, P and Cartasegna, L and Casabe, J and Casaccia, G and Castellanos, C and Castro, L and Cendali, G and Cerchi, P and Cerdan, M and Cinalli, M and Cipullo, M and Cismondi, M and Citta, N and Citta, L and Crespo, C and Crunger, P and Cuneo, C and De Loredo, L and De Loredo, S and Del Cerro, S and Denaro, R and Esperatti, E and Esposito, L and Farras, H and Fernandez, S and Fernandez, M and Fernandez, A and Ferrari, G and Focaccia, M and Frontini, L and Gabito, A and Gambarte, A and Garrido, M and Garrido, I and Guglielmotti, V and Hershson, A and Hoffman, V and Juarisit, G and Klyver, M and Lagrutta, M and Llanos, J and Liberman, A and Lobo Marquez, L and Lopez, R and Lowenstein, D and ... and The DREAM Trial Investigators and DREAM Trial Investigators
The New England Journal of Medicine, ISSN 0028-4793, 10/2006, Volume 355, Issue 15, pp. 1551 - 1562
Journal Article